2008
$106M
from 9 investors over 9 rounds
NGM Biopharmaceuticals raised $106M on March 25, 2015
Investors: Greenspring Associates
NGM Biopharmaceuticals raised $58M on March 23, 2015
Investors: The Column Group
NGM Biopharmaceuticals raised $50M on July 18, 2013
Investors: Solon Mack Capital and Prospect Venture Partners, LP
NGM Biopharmaceuticals raised $55M on November 7, 2011
Investors: Prospect Venture Partners, LP, The Column Group and Rho Ventures
NGM Biopharmaceuticals raised $27M on December 22, 2009
Investors: The Column Group and Prospect Venture Partners, LP